Dow Up 0.11% Nasdaq Up 0.30%

OncoMed Pharmaceuticals, Inc. (OMED)

-NasdaqGS
20.07 Up 0.26(1.31%) 9:54AM EDT - Nasdaq Real Time Price
Prev Close:19.81
Open:20.00
Bid:19.53 x 500
Ask:19.91 x 300
1y Target Est:40.67
Beta:1.637
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:19.70 - 20.14
52wk Range:12.07 - 42.34
Volume:33,160
Avg Vol (3m):178,434
Market Cap:597.28M
P/E (ttm):N/A
EPS (ttm):-1.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OMED

Comparison

Symbol% ChgMkt Cap
OMEDUp 1.31%597.28M
STMLUp 2.10%169.85M
VSTMUp 1.56%235.68M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.50
Quarterly EPS Est (Sep-14) :-0.30
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoMed Pharmaceuticals, Inc., a clinical development-stage biotechnology company, focuses on discovering and developing monoclonal antibody therapeutics targeting cancer stem Cells (CSCs). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback